SAN FRANCISCO--(BUSINESS WIRE)--Brightside Health, a telehealth platform that delivers life-saving mental health care to individuals with mild-to-severe clinical depression, anxiety, and other mood disorders, announced today the appointment of Matt Mohebbi as Head of Artificial Intelligence (AI) and Research. Brightside Health has been committed to the power of data-driven decision making and process automation from the beginning, as exemplified by its proprietary precision prescribing tool, PrecisionRx. In his new role, Mohebbi will substantially expand and accelerate Brightside Health’s AI and data efforts to further improve quality and efficiency for members, providers, and administrators on the company’s platform.
“Matt is a natural addition to the Brightside Health team as AI introduces new ways to advance quality and efficiency in the healthcare industry. He will play a key role in ensuring our technology continues to improve mental health patient outcomes across the entire clinical spectrum, affordably and at scale,” said Brad Kittredge, co-founder and CEO, Brightside Health. “His impressive background as both a startup founder and engineering leader will be key to implementing tactical use cases of AI to further enhance the care our members receive.”
With 15 years of engineering experience, Mohebbi is passionate about using AI at scale to solve real-world problems. Prior to joining Brightside Health, he was a VP of Engineering at GoodRx, managing the engineering teams responsible for core products and technologies. He also co-founded and served as CTO of Iodine (acquired by GoodRx), a startup that helped millions of Americans find the best medicine for them, and worked as a Software Engineer at Google, where he co-created Google Flu Trends.
“I am thrilled to join Brightside Health and help further their mission to deliver mental health care that Americans deserve,” said Mohebbi. “With the recent advancements in generative AI, it is an especially exciting time to work at the intersection of healthcare and AI. I look forward to expanding Brightside Health’s use of AI to offer more personalized care to every patient, including those at elevated risk of suicide.”
Mohebbi’s appointment follows that of Chris Murray as CFO and Julia Bernstein as COO, as well as the company’s expansion to serve Medicaid and Medicare beneficiaries. For more information about Brightside Health, visit www.brightside.com.
About Brightside Health
Brightside Health delivers life-saving mental health care to people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk. Powered by proprietary AI, purpose-built technology, and a world-class clinician network, Brightside Health combines precision psychiatry and leading-edge therapeutic techniques to improve patient outcomes across the entire clinical spectrum, affordably and at scale, with appointments available in 48 hours or less. Brightside Health can be paid for with insurance or out of pocket in all 50 states and D.C., and will begin offering services to Medicare and Medicaid beneficiaries. Learn more at www.brightside.com.
